Please check your internet connection and try again.
# Sporidex (cephalexin) For UTI Prophylaxis
## Overview
Cephalexin is a first-generation cephalosporin antibiotic. While not the first-line agent for UTI prophylaxis (which typically includes nitrofurantoin or trimethoprim-sulfamethoxazole), it is used in patients with contraindications or intolerance to first-line agents, or during pregnancy.
## Primary Indications
Prevention of recurrent urinary tract infections (UTIs) in patients who have failed or are unsuitable for primary prophylaxis agents.
## Adult Dosing
* **Standard Regimen:** 125 mg to 250 mg taken orally once daily at bedtime.
* **Maximum Dose:** Typically 250 mg daily for prophylaxis. Higher doses are generally reserved for active infection treatment.
## Pediatric Dosing
* **Standard Regimen:** 10 mg/kg to 15 mg/kg once daily at bedtime.
* **Maximum Dose:** Do not exceed 250 mg daily.
## Dose Adjustments
* **Renal Impairment:** Reduce frequency or dose if CrCl < 30 mL/min. Specific prophylaxis guidelines vary significantly by local antibiogram and institution; consult renal dosing protocols.
* **Hepatic Impairment:** No specific adjustment required.
## Contraindications
* Known hypersensitivity to cephalexin or other cephalosporins.
* History of severe immediate hypersensitivity (e.g., anaphylaxis, angioedema) to penicillins or other beta-lactams (cross-reactivity risk).
## Adverse Effects
* **Common:** Diarrhea, nausea, vomiting, abdominal pain.
* **Serious:** *Clostridioides difficile*-associated diarrhea, hypersensitivity reactions (rash, urticaria), and secondary fungal infections (e.g., vulvovaginal candidiasis).
## Key Drug Interactions
* **Probenecid:** Decreases renal excretion of cephalexin, leading to increased serum concentrations.
* **Metformin:** May increase metformin levels (monitor for lactic acidosis).
* **Warfarin:** May increase INR/bleeding risk due to alteration of gut flora (vitamin K synthesis).
## Monitoring
* **Efficacy:** Monitor for breakthrough UTI symptoms (dysuria, frequency, urgency, fever).
* **Safety:** Baseline and periodic renal function monitoring. Monitor for signs of *C. difficile* infection (persistent diarrhea).
* **Resistance:** Periodically assess for development of resistant organisms via urine culture if symptoms recur.
## Clinical Pearls
* **Local Protocols:** Prophylaxis duration and choice are heavily dictated by local resistance patterns. Always confirm with local institutional policy or infectious disease guidelines.
* **Administration:** Can be taken with or without food.
* **Pregnancy:** Considered a safe alternative for UTI prophylaxis in pregnant patients.
* **Compliance:** Stress the importance of taking the dose consistently at bedtime to ensure high concentration in the bladder overnight.
***
**Disclaimer:** This information is for educational purposes only. Always verify current prescribing information, local antibiograms, and institutional guidelines through official clinical resources (e.g., Lexicomp, UpToDate) or the drug manufacturer before prescribing or administering medication.
